Endocare, Inc. NEW Common Stock
ENDO
ENDO was delisted on the 27th of July, 2009.
0 hedge funds and large institutions have $0 invested in Endocare, Inc. NEW Common Stock in 2014 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $205K → $0 (-$205K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
Aspen Investment Management
Grand Rapids,
Michigan
|
-$205K |
ENDO Hedge Fund Activity: Q4 2014 in Review
0 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Endocare, Inc. NEW Common Stock (ENDO) for Q4 2014, worth a combined $0 — down 100% from $205K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ENDO and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Aspen Investment Management, exiting entirely with an estimated $205K sold.
- 0 institutional investors held Endocare, Inc. NEW Common Stock (ENDO) as of Q4 2014, down from 1 in Q3 2014.
- Funds reported $0 of Endocare, Inc. NEW Common Stock stock for Q4 2014, down 100% quarter-over-quarter.
- 0 funds opened new Endocare, Inc. NEW Common Stock positions in Q4 2014 and 1 closed out, a net change of -1 holder.
- The largest Endocare, Inc. NEW Common Stock seller in Q4 2014 was Aspen Investment Management, an estimated $205K sold.
Based on aggregated 13F filings for Q4 2014.